High materiality7/10
Jazz Pharmaceuticals price target raised to $283 from $280 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
JAZZ target raised to $283; current price $252.2; upside implied.
- Target: $283
- Posted price: $252.2
- Analyst firm: Morgan Stanley
- Analyst: (not specified)
Key facts
- 01
Target: $283
- 02
Posted price: $252.2
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.